MEET US NEXT
Team Leader Dr. Jarno M. A. Tanskanen
& The Team
Prof. Jari Hyttinen
Team Leader Dr. Jarno M. A. Tanskanen
& The Team
Prof. Jari Hyttinen
MEET US NEXT
ReOrgan — Real-time Assessment of Organ Transplant Degradation Post-procurement
ReOrgan project aims at commercialization readiness of human organ transplant quality assessment. The project is the next step for the team after the Business Finland funded Research to Business project OrganAnalytics led by Jarno Tanskanen in collaboration with Jari Hyttinen and his team.
There is global urgent demand for transplant organs. For example, for Eurotransplant operating in eight European countries, 10099 new patients entered waiting lists during 2023. In the US, doctors may turn down several life-saving organs instead of taking the risk of using an organ of a borderline quality. ReOrgan aims to be a part of that transition and develop a safe real-time method to assess the condition of the donated organs and provide clinicians more tools and accurate information on the condition of the transplant. The US has set a goal to decrease the amount of donated but unused kidneys from 25% to 5%.“Our endeavor ultimately aims at an FDA approved and CE marked clinical device. ReOrgan allow us to strengthen the science base and produce a prototype of the intended transplant assessment device during the project,”The Distinguished Innovator Grant awarded by the Novo Nordisk Foundation was received at the perfect time for keeping the momentum in bringing the device to market.
the project leader Prof. Hyttinen sums up.
“A crucial part of the work is preparing commercialization. For this task, we are lucky to have an experienced Business Developer Donna Kivirauma in the team,”
he continues.
“Furthermore, the Novo Nordisk Foundation Distinguished Innovator awardee network with yearly on-site meetings at the Novo Nordisk campus provides excellent platform for Nordic networking,”
Hyttinen comments.
OrganAnalytics — Viability Analysis of Organ Transplants
Donna Kivirauma won the Best Piching Case Award at the Nordic Innovation Fair 23 for OrganAnalytics on September 26, 2024.
Each year the Nordic Innovation Fair, held in Copenhagen and sponsored by the Novo Nordisk foundation, selects 30 of the best innovations in Medtech & Diagnostics, Biotech & Pharma, Greentech & Food Quantum, AI & Digital from across the Nordics. Researchers and spin-outs from Sweden, Norway, Finland, Iceland, and Denmark participate in the competition. In September of 2023 OrganAnalytics was selected among the top 30 submissions and subsequently won the best pitch in the category of Medtech & Diagnostics.
According to the NIF website,
"The cases were evaluated from the following selection criteria:
- Business potential – The potential market of customers for the presented product is attractive and the business model is strong
- Team experience – Company/project team has skills and experience to grow the business and can work with industry & research entities
- Product/Technology merit – Technology or product solutions developed are state-of-the-art and well advanced compared to competitors
- Competitive position – The intellectual property of the company/project and its competences and strategic relations are outstanding
- lnvestment or partnering interest – Offer to invest in or partner with your assigned company is well defined and attractive for interested parties
- Project profile quality – Information available from company/project profile sheet is complete, clear, balanced and convincing, and additionally supported well by the provided visual slide deck.
"Thank you Nordic Innovation Fair! The experience was amazing. Great contacts, pitches, and innovation. Honored to be chosen as a best pitch winner. Congratulations to the other winners!" <3 Donna
From University Research and Innovation towards the Clinic
OrganAnalytics is a part of the Smart Life Finland Program of Business Finland, and a SPARKee with SPARK Finland, a member of the SPARK Global Network.